Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice

Agents Actions. 1986 Dec;19(5-6):313-4. doi: 10.1007/BF01971235.
No abstract available

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Autoimmune Diseases / drug therapy*
  • Isoxazoles / therapeutic use*
  • Leflunomide
  • Lupus Erythematosus, Systemic / drug therapy*
  • Mice
  • Mice, Inbred Strains
  • Oxazoles / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Isoxazoles
  • Oxazoles
  • Leflunomide